abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Equity Ratio
99.57%
Quarterly · Period ending:
HQL Equity Ratio
Latest reported99.57%period ending
Latest reported99.57%period ending
HQL Quarterly Equity Ratio (99.51% → 99.57%)
Latest values, visible window
High-resolution chart · PNG
HQL equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| 99.574% | |
| 99.6651% | |
| 96.2562% | |
| 99.8071% | |
| 99.8009% | |
| 99.8343% | |
| 97.6788% | |
| 95.9436% | |
| 97.1151% | |
| 97.9885% | |
| 99.8709% | |
| 99.8771% | |
| 99.8545% | |
| 99.1393% | |
| 99.5682% | |
| 99.3776% | |
| 99.843% | |
| 99.5768% | |
| 99.8724% | |
| 99.3631% | |
| 99.8229% | |
| 98.9283% | |
| 98.5823% | |
| 99.8305% | |
| 99.8375% | |
| 99.825% | |
| 99.4958% | |
| 99.8221% | |
| 99.4172% | |
| 98.5061% | |
| 97.8972% | |
| 95.8038% | |
| 93.7759% | |
| 96.3926% | |
| 98.8612% | |
| 99.2713% | |
| 99.6441% | |
| 99.3447% | |
| 99.003% | |
| 99.2616% | |
| 99.5658% | |
| 99.4568% | |
| 99.3268% | |
| 98.9899% | |
| 98.6528% | |
| 99.1736% | |
| 99.81% | |
| 99.7325% | |
| 99.6758% | |
| 98.6193% | |
| 99.8487% | |
| 99.6874% | |
| 99.515% |